PERSIMMON PUBLIC LIMITED COMPANY financials
PERSIMMON PUBLIC LIMITED COMPANY
213800XI72Y57UWN6F31 | Line item | 2025 | 2024 |
|---|---|---|
| Income statement | ||
| Revenue | £3.75B | £3.20B |
| Cost of sales | £3.13B | £2.62B |
| Gross profit | £616.5M | £580.4M |
| Operating expenses | £225.2M | £196.0M |
| Operating profit (EBIT) | £423.8M | £369.2M |
| Finance costs | £37.9M | £21.2M |
| Profit before tax | £397.3M | £359.1M |
| Income tax expense | £111.6M | £92.0M |
| Profit for the year | £285.7M | £267.1M |
| — attributable to owners | £285.7M | £267.1M |
| Total comprehensive income | £280.9M | £266.0M |
| Per share | ||
| Basic EPS | £0.89 | £0.84 |
| Diluted EPS | £0.88 | £0.83 |
| Free cash flow / share | £-0.03 | £0.16 |
| Cash flow statement | ||
| Cash generated from operations | £138.5M | £186.9M |
| Net cash from operating activities | £29.5M | £84.9M |
| Net cash from investing activities | £26.8M | -£45.0M |
| Purchase of PP&E (capex) | £40.6M | £32.3M |
| Net cash from financing activities | -£197.9M | -£201.4M |
| Dividends paid | £192.1M | £191.8M |
| Lease liability payments | £5.1M | £4.0M |
| Balance sheet | ||
| Total assets | £5.32B | £4.83B |
| Non-current assets | £454.4M | £485.1M |
| Property, plant & equipment | £115.4M | £154.6M |
| Intangible assets & goodwill | £182.5M | £164.6M |
| Current assets | £4.86B | £4.35B |
| Inventories | £4.49B | £3.90B |
| Trade & other receivables | £249.9M | £167.8M |
| Cash & equivalents | £117.0M | £258.6M |
| Total equity | £3.61B | £3.51B |
| Non-current liabilities | £486.1M | £403.5M |
| Current liabilities | £1.22B | £923.3M |
| Trade & other payables | £1.12B | £806.3M |
| Deferred tax liabilities | £54.4M | £73.1M |
| Derived metrics | ||
| Free cash flow | -£11.1M | £52.6M |
| Operating margin | 11.3% | 11.5% |
| Net margin | 7.6% | 8.3% |
| Return on equity | 7.9% | 7.6% |
| Cash conversion ratio | 0.10× | 0.32× |
| Capex coverage | 0.73× | 2.63× |
| Other reported items | ||
| Adjustments For Amortisation Expense | £100.0K | £0 |
| Adjustments For Decrease Increase In Inventories | -£590.1M | -£200.4M |
| Adjustments For Decrease Increase In Trade and Other Receivables | -£84.7M | £12.7M |
| Adjustments For Depreciation Expense | £21.1M | £20.1M |
| Adjustments For Finance Costs | £37.9M | £21.2M |
| Adjustments For Finance Income | £11.4M | £11.1M |
| Adjustments For Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | £3.4M | £1.6M |
| Adjustments For Income Tax Expense | £111.6M | £92.0M |
| Adjustments For Increase Decrease In Trade and Other Payables | £321.4M | -£49.6M |
| Adjustments For Interest Income | £18.3M | £10.0M |
| Adjustments For Sharebased Payments | £16.1M | £14.7M |
| Capital Redemption Reserve | £236.5M | £236.5M |
| Cash Flows From Losing Control of Subsidiaries Or Other Businesses Classified As Investing Activities | £68.1M | £0 |
| Cash Flows From Used In Operations Before Changes In Working Capital | £487.9M | £419.6M |
| Cash Flows Used In Obtaining Control of Subsidiaries Or Other Businesses Classified As Investing Activities | £3.5M | £0 |
| Current Provisions | £83.2M | £111.4M |
| Current Tax Assets | £2.5M | £15.8M |
| Deferred Tax Assets | £0 | £9.2M |
| Dividends Proposed Or Declared Before Financial Statements Authorised For Issue But Not Recognised As Distribution To Owners Per Share | £0.40 | — |
| Finance Income | £11.4M | £11.1M |
| Income Tax Relating To Components of Other Comprehensive Income That Will Not Be Reclassified To Profit Or Loss | -£1.9M | -£400.0K |
| Income Taxes Paid Refund Classified As Operating Activities | £96.1M | £97.8M |
| Increase Decrease In Cash and Cash Equivalents | -£141.6M | -£161.5M |
| Increase Decrease Through Sharebased Payment Transactions | £18.5M | £14.0M |
| Interest Paid Classified As Operating Activities | £16.7M | £9.3M |
| Interest Received Classified As Operating Activities | £3.8M | £5.1M |
| Investment Accounted For Using Equity Method | £300.0K | £300.0K |
| Investments In Subsidiaries | £0 | £0 |
| Issue of Equity | £2.5M | £100.0K |
| Issued Capital | £32.1M | £32.0M |
| Liabilities | £1.70B | £1.33B |
| Miscellaneous Other Operating Income | £21.4M | £9.8M |
| Net Assets Liabilities | £3.61B | £3.51B |
| Noncurrent Payables | £283.1M | £196.2M |
| Noncurrent Provisions | £142.8M | £123.9M |
| Noncurrent Receivables | £1.9M | £0 |
| Noncurrent Recognised Assets Defined Benefit Plan | £130.7M | £130.7M |
| Other Adjustments For Noncash Items | -£700.0K | -£500.0K |
| Other Comprehensive Income | -£4.8M | -£1.1M |
| Other Comprehensive Income Before Tax Gains Losses On Remeasurements of Defined Benefit Plans | -£6.7M | -£1.5M |
| Payments To Acquire Or Redeem Entitys Shares | £2.3M | £200.0K |
| Proceeds From Exercise of Options | £2.5M | £100.0K |
| Proceeds From Sales of Property Plant and Equipment Classified As Investing Activities | £2.8M | £4.8M |
| Purchase of Treasury Shares | £2.3M | £200.0K |
| Retained Earnings | £3.04B | £2.94B |
| Share Premium | £28.0M | £25.6M |
Every line item above is a fact tagged in PERSIMMON PUBLIC LIMITED COMPANY's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (GBP), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.